Director/PDMR Shareholding

25 July 2011

Synergy Health plc ("Synergy" or the "Company")

Director/PDMR Shareholding

The company has been informed on 22 July 2011 of the following exercise of options over ordinary shares of 0.625 pence each ("Ordinary Shares") granted under the Synergy Health Long Term Incentive Plan.

Adrian Coward, CEO UK and Ireland, exercised an option over 5,071 ordinary shares at 0.625 pence. He has retained these shares and allocated 4,748 shares to the LTIP Co-Invest scheme. As such, Adrian Coward has been awarded 9,496 LTIP Co-Invest options. Following this transaction, Mr Coward has an interest in 11,130 Ordinary Shares, representing 0.02% of the Company's issued share capital.

Paul Santing, Group Commercial Director, exercised an option over 6,925 ordinary shares at 0.625 pence. He has retained these shares and allocated them to the LTIP Co-Invest scheme. As such, Paul Santing has been awarded 13,850 LTIP Co-Invest options. Following this transaction, Mr Santing has an interest in 14,680 Ordinary Shares, representing 0.027% of the Company's issued share capital.

The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-Invest.

Enquiries

Tim Mason

Company Secretary

01793 891862